New Kelyniam Chair and CEO was Former Stryker Marketing Director

Joseph Delligatti has been named CEO and chairman of the board of Kelyniam Global, maker of the Cadcam for replication of artificial bone implants, according to a release from Kelyniam Global.

Advertisement

Mr. Delligatti was the director of sales and marketing for Stryker Corp.’s Physiotherapy Associates division from 2005-2007.

He succeeds James Ketner, who will remain on the board of directors of the Little Rock, Ark.-based company.

Read the release on the new Kelyniam Global CEO.

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in Uncategorized

Advertisement

Comments are closed.